IHS Chemical Week

Chemical Week Magazine :: Companies

Merck KGaA May Divest Generics

1:07 PM MDT | July 18, 2007 | Chemical Week Editorial Staff

Merck KGaA is considering plans to divest its generic drugs business and could raise up to €4 billion ($5.3 billion) from the sale, according to a report in German newspaper Handelsblatt on January 4. Merck KGaA declined to comment on the report. Selling generics would cut Merck KGaA’s debt following the company’s imminent purchase of biotechnology firm Serono for over $13 billion. Private equity firms, rather than pharmaceutical manufacturers, are more likely to be interested in buying Merck KGaA’s generics, analysts say. Merck KGaA is one...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2014 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa